MIRA Pharmaceuticals, Inc.
1200 Brickell Avenue, Suite 1950 #1183,
Miami, Florida 33131
August 15, 2024
VIA EDGAR
U.S. Securities & Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Re: | MIRA Pharmaceuticals, Inc. | |
| Registration Statement on Form S-3 | ||
| File No. 333-281467 |
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, MIRA Pharmaceuticals, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on Friday, August 16, 2024, or as soon thereafter as possible.
* * * *
Very Truly Yours,
| MIRA Pharmaceuticals, Inc. | |
| /s/ Erez Aminov | |
| Erez Aminov | |
| Chief Executive Officer |